MIA
GMAB icon

Madison Investment Advisors’s Genmab GMAB Stock Holding History

Madison Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$979K Buy
+46,904
New +$1.03M 0.01% 285

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Madison Investment Advisors's GMAB Position: Q4 2024 in Review

Madison Investment Advisors opened a new position in Genmab (GMAB) in Q4 2024: 46,904 shares worth $979K. The stake represents 0.01% of the portfolio and ranks #285 among its holdings.

229 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Madison Investment Advisors held 46,904 shares of Genmab worth $979K as of Q4 2024.
  • Genmab was a new Madison Investment Advisors position in Q4 2024.
  • Genmab made up 0.01% of Madison Investment Advisors's portfolio in Q4 2024, its #285 holding.
  • 229 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Madison Investment Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.